The neurobiological characteristics of rapid eye movement (REM) sleep are candidate endophenotypes of depression, schizophrenia, mental retardation and dementia

Progress in Neurobiology

Volumn 81, Issue 4, 2007, Pages 237-250

  Gottesmann, Claude ^a   Gottesman, Irving ^b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Dreaming; Mental illness; Paradoxical sleep

Indexed keywords

DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MENTAL DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; REM SLEEP; REVIEW; SCHIZOPHRENIA; SLEEP DISORDER;

ANIMALS; DEMENTIA; DEPRESSION; HUMANS; MENTAL RETARDATION; NEUROBIOLOGY; SCHIZOPHRENIA; SLEEP, REM;

EID: 33947692221     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2007.01.004     Document Type: Review

References (285)

1. Abi-Dargham A., and Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9 (2003) 404-416
2. Adrien J. Neurobiological bases for the relation between sleep and depression. Sleep Med. Rev. 6 (2002) 341-351
3. Aghajanian G.K., Foot W., and Sheard M. Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science 161 (1968) 706-708
4. Aldrich M.S. The neurobiology of the narcolepsy-cataplexy syndrome. Int. J. Neurol. 25-26 (1991) 29-40
5. Alexandre C., Popa D., Fabre V., Bouali S., Venault P., Lesch K.P., Hamon M., and Adrien J. Early-life blockade of 5-HT1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J. Neurosci. 17 (2006) 5554-5564
6. Araneda R., and Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in the association cortex. Neuroscience 40 (1991) 399-412
7. Aserinsky E., and Kleitman N. Regularly occurring periods of eye motility, and concomitant phenomena during sleep. Science 118 (1953) 273-274
8. Aston-Jones G., and Bloom F.E. Activity of norepinephrine-containing neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1 (1981) 876-886
9. Aston-Jones G., and Bloom F.E. Norepinephrine-containing locus coeruleus neurons in behaving rat exhibit pronounced responses to non-noxious environmental stimuli. J. Neurosci. 1 (1981) 887-900
10. Baghdoyan H.A. Cholinergic mechanisms regulating REM sleep. Sleep Sci.: Basic Res. Clin. Prac. Monogr. Clin. Neurosci. (1997) 88-116
11. Battaglia M., Strambi L.F., Bertella S., Bajo S., and Bellodi L. First-cycle REM density in never-depressed subjects with borderline personality disorder. Biol. Psychiat. 45 (1999) 1056-1058
12. Behrendt R.P., and Young C. Hallucinations in schizophrenia, sensori impairment and brain disease: an unified model. Behav. Brain Sci. 27 (2005) 771-787
13. Benes F.M., Matzilevitch D., Burke R.E., and Walsh J. The expression of proapoptisis genes is increased in bipolar disorder, but not in schizophrenia. Mol. Psychiat. 11 (2005) 1-11
14. Benson K.L., and Zarcone V.P.J. Rapid eye movement sleep eye movements in schizophrenia and depression. Arch. Gen. Psychiat. 50 (1993) 474-482
15. Berger R. Tonus of extrinsic laryngeal muscles during sleep and dreaming. Science 134 (1961) 840
16. Berrettini W.H. Genetic bases for endophenotypes in psychiatric disorders. Dial Clin. Neurosci. 7 (2005) 95-101
17. Blagrove M., Blakemore S.J., and Thayer B.R.J. The ability to self-tickle following rapid eye movement sleep dreaming. Conscious Cogn. 15 (2006) 285-294
18. Bokkon I. Dreams and neuroholography: an interdisciplinary interpretation of development of homeotherm state in evolution. Sleep Hypnosis 7 (2005) 61-76
19. Bosinelli M. Mind and consciousness during sleep. Brain Res. 69 (1995) 195-201
20. Bourgin P., Huitron-Resendiz S., Spier A.D., Fabre V., Morte B., Criado J.R., Siutcliffe J.G., Henriksen S.I., and Lecea de L. Hypocretin-I modulatesz rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci. 20 (2000) 7760-7765
21. Boutrel B., Franc B., Hen R., Hamon M., and Adrien J. Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice. J. Neurosci. 19 (1999) 3204-3214
22. Bouyer J.J., Montaron M.F., and Rougeul A. Fast fronto-parieta rhythms during combined focused attentive behavior and immobility in cat: cortical and thalamic localizations. Electroenceph Clin. Neurophysiol. 51 (1981) 244-252
23. Braff D.L., Freedman R., Schork N.J., and Gottesman I.I. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr. Bull. 33 (2007) 21-32
24. Brake W.G., Flores G., Francis D., Meaney M.J., Srivastava L.K., and Gratton A. Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex. Neuroscience 96 (2000) 687-695
25. 15O PET study. Brain 120 (1997) 1173-1197
26. Braun A.R., Balkin T.J., Wesensten N.J., Gwardry F., Carson R.E., Varga M., Baldwin P., Belenky G., and Herscovitch P. Dissociated pattern of activity in visual cortices and their projections during human rapid eye movement sleep. Science 279 (1998) 91-95
27. Bremer F. Cerveau "isolé" et physiologie du sommeil. C.R. Soc. Biol. 118 (1935) 1235-1241
28. Broughton R.J., Poiré R., and Tassinari C.A. The electrodermogram (Tarchanoff effect) during sleep. Electroenceph Clin. Neurophysiol. 18 (1965) 691-708
29. Buffenstein A., Heaster J., and Ko P. Chronic psychotic illness from amphetamine. Am. J. Psychiat. 156 (1999) 662
30. Buschbaum M.S., Ingvar D.H., Kessler R., Waters R.N., Cappelletti J., Van Kammen D.P., King A.C., Johnson J.L., Manning R.G., Flynn R.W., Bunney W.E.J., and Sokoloff L. Cerebral glucography with positron tomography, use in normal subjects and in patients with schizophrenia. Arch. Gen. Psychiat. 39 (1982) 251-259
31. Cadilhac J., Baldy-Moulines M., and Delange M. Sommeil diurne et sommeil nocturne dans la narcolepsie. Riv. Neurol. 36 (1966) 94-107
32. Callaway C.W., Lydic R., Bagdoyan H.A., and Hobson J.A. Pontogeniculooccipital waves: spontaneous visual system activity during rapid eye movement sleep. Cell Mol. Neurobiol. 7 (1987) 105-149
33. Cantero J.L., Atienza M., Madsen J.R., and Stickgold R. Gamma EEG dynamics in neocortex and hippocampus during human wakefulness and sleep. Neuroimage 22 (2004) 1271-1280
34. Chergui K., Suaud-Chagny M.F., and Gonon F. Non-linear relationship between impulse flow. Dopamine release and dopamine elimination in the rat in vivo. Neuroscience 62 (1994) 641-645
35. Christos G.A. Is Alzheimer's disease related to a deficit or malformation of rapid eye movement (REM) sleep?. Med. Hypotheses 41 (1993) 435-439
36. Cirelli C. A molecular window on sleep: changes in gene expression between sleep and wakefulness. Neuroscientist 11 (2005) 63-74
37. Clark C., Dupont R., Golshan S., Gillin J.C., Rapaport M.H., and Kelsoe. Preliminary evidence of an association between increased REM density and poor antidepressant response to partial sleep deprivation. J. Affect Disord. 59 (2000) 77-83
38. Clementz B.A., Geyer M.A., and Braff D.L. Poor P50 suppression among schizophrenic patients and their first-degree relatives. Am. J. Psychiat. 155 (1998) 1691-1694
39. Cohen H.B., and Dement W.C. Sleep: suppression of rapid eye movement phase in the cat after electroconvulsive shock. Science 154 (1966) 396-398
40. Cohen H.B., Duncan II R.F., and Dement W.C. Sleep: the effect of electroconvulsive shocks in cats deprived of REM sleep. Science 156 (1967) 1648-1746
41. Collerton D., Perry E., and McKeith I. A novel perception and attention deficit model for recurrent visual hallucinations. Brain Behav. Sci. 28 (2005) 737-757
42. Cordeau J.P., Moreau A., Beaulnes A., and Laurin C. EEG and behavioral changes following microinjections of acetylcholine and adrenaline in the brain stem of cats. Arch. Ital. Biol. 101 (1963) 30-47
43. Crick F., and Michison G. The function of dream sleep. Nature 304 (1983) 111-114
44. Dagnino N., Favale E., Loeb C., Manfredi M., and Seitun A. Presynaptic and postsynaptic changes in specific thalamic nuclei during deep sleep. Arch. Ital. Biol. 107 (1969) 668-684
45. Dahlstrom A., and Fuxe K. Evidence for existence of monoamine-containing neurons in the central nervous system. Acta Physiol. Scand. 62 Suppl. 232 (1964) 3-55
46. Datta S., and Siwek D.F. Excitation of the brainstem pedunculopontine tegmentum cells induces wakefulness and REM sleep. J. Neurophysiol. 77 (1997) 2975-2988
47. Datta S., Spoley E.E., and Patterson E.H. Microinjection of glutamate into the pedunculopontine tegmentum induces REM sleep and wakefulness in the rat. Am. J. Physiol. 280 (2001) R752-R759
48. DeBastita C., Lemke A., Solvason H., Ghebremichael R., and Poirier J. A prospective trial of modafinil as an adjunctive treatment of major depression. J. Clin. Psychopharmacol. 24 (2004) 87-90
49. Delay J., Deniker P., and Harl J.M. Traitement des états d'excitation et d'agitation par une méthode médicamenteuse dérivée de l'hibernothérapie. Ann. Med. Psychol. 110 (1952) 267-273
50. Delfs J.M., Zhu Y., Druhan J.P., and Aston-Jones G.S. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res. 806 (1998) 127-140
51. Dement W., and Kleitman N. Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroenceph Clin. Neurophysiol. 9 (1957) 673-690
52. Dement W.C. The occurrence of low voltage fast electroencephalogram patterns during behavioral sleep in the cat. Electroenceph Clin. Neurophysiol. 10 (1958) 291-296
53. Demetrescu M., Demetrescu M., and Iosif G. Diffuse regulation of visual thalamo-cortical responsiveness during sleep and wakefulness. Electroenceph Clin. Neurophysiol. 20 (1966) 450-469
54. Depoortere H., and Loew D.M. Motor phenomena during sleep in the rat: a mean of improving the analysis of the sleep-wakefulness cycle. In: Jovanovic U. (Ed). The Nature of Sleep (1973), Gustav Fisher, Stuttgart 101-104
55. Descarries L., Beaudet A., and Watkins K.C. Serotonin nerve terminals in the adult rat neocortex. Brain Res. 100 (1975) 563-588
56. Descarries L., Watkins K.C., and Lapierre Y. Noradrenergic axon terminals in the cerebral cortex of rats. III. Topometric ultrastructural analysis. Brain Res. 133 (1977) 197-222
57. Douglass A.B. Narcolepsy: differential diagnosis or etiology in some cases of bipolar disorder and schizophrenia. CNS Spectr. 8 (2003) 120-126
58. Dugovic C., Solberg L.C., Redei E., Van Reeth O., and Turek F.W. Sleep in the Wistar-Kyoto rat, a putative genetic animal model for depression. Neuroreport 11 (2000) 627-631
59. Dunleavy D.L.F., and Oswald I. Phenelzine, mood response, and sleep. Arch. Gen. Psychiat. 28 (1973) 353-356
60. Dzirasa K., Ribeiro S., Costa R., Santos L.M., Lin S.-C., Grosmark A., Sotnikova T.D., Gainetdinov R.R., Caron M.G., and Nicolelis M.A.L. Dopaminergic control of sleep-wake states. J. Neurosci. 26 (2006) 10577-10589
61. 3 receptors in raft-like domains. J. Neurosci. 25 (2005) 10198-10206
62. Evarts E.V. Temporal patterns of discharge of pyramidal tract neurons during sleep and waking in the monkey. J. Neurophysiol. 27 (1964) 152-171
63. Evarts, E.V., 1965. Neuronal activity in visual and motor cortex during sleep and waking. In: Aspects anatomo-fonctionnels de la physiologie du sommeil. CNRS ed., Paris, pp. 189-212.
64. Feinberg I., Koresco R.L., Gottlieb F., and Wender P.H. Unusually high dream time in an hallucinating patient. Am. J. Psychiat. 121 (1964) 1018-1020
65. Fletcher P.C., McKenna P.J., Frith C.D., Grasby P.M., Friston K.J., and Dolan R.J. Brain activation in schizophrenia during a graded memory taski studied with functional neuroimaging. Arch. Gen. Psychiat. 55 (1998) 1001-1008
66. Foote S.L., Freedman R., and Oliver A.P. Effects of putative neurotransmitters on neuronal activity on monkey auditory cortex. Brain Res. 86 (1975) 229-242
67. Fouks L., Laine, Grimaud, and Dariotis. La fin des thérapeutiques de choc et l'avènement de nouvelles thérapeutiques psychiatriques actives. Ann. Médico-Psychol. 112 (1954) 764-768
68. Foulkes W.D. Dream reports from different stages of sleep. J. Abnormal Soc. Psychol. 65 (1962) 14-25
69. Foutz A., Mitler M.M., Cavalli-Sforza L.L., and Dement W.C. Genetic factors in canine narcolepsy. Sleep 1 (1979) 280-286
70. Franken P., Djik D.J., Tobler I., and Borbely A.A. High-frequency components of the rat electrocorticogram are modulated by the vigilance states. Neurosci. Lett. 167 (1994) 89-92
71. Frederickson R.C.A., Jordan L.M., and Phillis J.W. The action of noradrenaline on cortical neurons: effects of pH. Brain Res. 35 (1971) 556-560
72. Freis E.D. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N. Engl. J. Med. 251 (1954) 1006-1008
73. Freud S. The interpretation of dreams (1900), The Hogart Press, London 1955
74. Freud, S., 1925. A note upon the " mystic writing-pad", standard ed., vol. 19. The Hogart Press, London, pp. 227-232.
75. Friedman J.I., Adler D.N., and Davis K.L. The role of norepinephrine in the physiopathology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biol. Psychiat. 46 (1999) 1243-1252
76. Fruhstorfer B., Mignot E., Bowersox S.S., Nishino S., Dement W., and Guilleminault C. Canine narcolepsy is associated with elevated number of alpha-2 receptors in the locus coeruleus. Brain Res. 500 (1989) 209-214
77. Fulton M.K., Armitage R., and Rush A.J. Sleep electroencephalographic coherence abnormalities in individuals at high risk for depression: a pilot study. Biol. Psychiat. 47 (2000) 618-625
78. Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta Physiol. Scand. 247 Suppl. (1965) 37-85
79. Fuxe K., Hamberger B., and Hökfelt T. Distribution of noradrenaline nerve terminals in cortical areas if the rat. Brain Res. 8 (1968) 125-131
80. Gaillard J.M., Martinoli R., and Kafi S. Automatic analysis of states of vigilance in the rat. Sleep 1976 (1977), Karger, Basel pp. 455-457
81. Gandolfo G., Arnaud C., and Gottesmann C. Transmission in the ventrobasal complex of rat during the sleep-waking cycle. Brain Res. Bull. 5 (1980) 921-927
82. Gastaut H., Duron B., Papy J.J., Tassinari C.A., and Waltregny A. Etude polygraphique comparative du cycle nycthémérique chez les narcoleptiques, les Pickwickiens, les obèses et les insuffisants respiratoires. Rev. Neurol. 115 (1966) 456-462
83. George R., Haslett W.L., and Jenden D.J. A cholinergic mechanism in the brainstem reticular formation: induction of paradoxical sleep. Int. J. Neuropharmacol. 3 (1964) 541-552
84. Ghelarducci B., Pisa M., and Pompeiano M. Transformation of somatic afferent volleys across the prethalamic and thalamic components of the lemniscal sytem during the rapid eye movements of sleep. Electroenceph Clin. Neurophysiol. 29 (1970) 348-357
85. Giles D.E., Biggs M.M., Rush A.J., and Roffwarg H. Risk factors in families of unipolar depression. I. Psychiatric illness and reduced REM latency. J. Affect Disord. 14 (1988) 51-59
86. Giles D.E., Jarret R.B., Roffwarg H., and Rush A.J. Reduced eye movement latency. A predictor of recurrence in depression. Neuropsychopharmacology 1 (1988) 33-39
87. Giles D.E., Jarret R.B., Rush A.J., Biggs M.M., and Roffwarg H. Prospective assessment of electroencephalographic sleep in remitted major depression. Psychiat. Res. 46 (1993) 269-284
88. Giles D.E., Kupfer D.J., Rush A.J., and Roffwarg H. Controlled comparison of electrophysiological sleep in families of probands with unipolar depression. Am. J. Psychiat. 155 (1998) 192-199
89. Gillin J.C., Sohn J.W., Stahl S.M., Lardon M., Kelsoe J., Rapaport M.H., Ruiz C., and Golshan S. Ipsapirone, a 5-HT1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls. Neuropsychopharmacology 15 (1996) 109-115
90. Gillin J.C., Wyatt R.J., Fram D., and Snyder F. The relationship between changes in REM sleep and clinical improvement in depressed patients with amitriptyline. Psychopharmacology 59 (1978) 267-272
91. Glin L., Arnaud C., Berracochéa D., Galey D., Jaffard R., and Gottesmann C. The intermediate stage of sleep in mice. Physiol. Behav. 50 (1991) 951-953
92. Goetz R.R., Wolk S.I., Coplan J.D., Ryan N.D., and Weissman M.M. Premorbid polysomnographic signs in depressed adolescents: a reanalysis of vEEG sleep after longitudinal follow-up in adulthood. Biol. Psychiat. 2001 (2001) 930-942
93. Goldman M., Tandon R., DeQuardo J.R., Taylor S.F., Goodson J., and McGrath M. Biological predictors of 1-year outcome in schizophrenia in males and females. Schizophr. Res. 21 (1996) 65-73
94. Goldsteinas L., Guennoc A., and Vidal J.C. Nouvelles données cliniques sur le vécu des "phases intermédiaires" du sommeil. Rev. Neurol. 115 (1966) 507-511
95. Goldsteinas L., and Lairy G.C. Etude du sommeil de nuit dans certains cas de confusion mentale. Rev. Neurol. 113 (1965) 284-290
96. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24 (1988) 19-28
97. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiat. 160 (2003) 636-645
98. Gottesman I.I., and Shields J. A polygenic theory of schizophrenia. Proc. Natl. Acad. Sci. USA 58 (1967) 199-205
99. Gottesman I.I., and Shields J. Genetic theorizing and schizophrenia. Br. J. Psychiat. 122 (1973) 15-36
100. Gottesmann C. Données sur l'activité corticale au cours du sommeil profond chez le rat. C.R. Soc. Biol. 158 (1964) 1829-1834
101. Gottesmann C. Identification d'une activité électrophysiologique phasique indépendante de la phase paradoxale du sommeil chez le rat. C.R. Soc. Biol. 160 (1966) 528-534
102. Gottesmann C. Données récentes sur les activités électrophysiologiques phasiques. Psychol. Franç. 12 (1967) 1-14
103. Gottesmann C. Recherche sur la psychophysiologie du sommeil chez le rat (1967), Presses du Palais Royal, Paris
104. Gottesmann C. Etude sur les activités électrophysiologiques phasiques chez le rat. Physiol. Behav. 4 (1969) 495-504
105. Gottesmann C. La psychophysiologie du sommeil. Bull. Psychol. 24 (1970) 520-528
106. Gottesmann C. Psychophysiologie du sommeil. Ann. Psychol. 71 (1971) 451-488
107. Gottesmann C. The transition from slow wave sleep to paradoxical sleep: evolving facts and concepts of the neurophysiological processes underlying the intermediate stage of sleep. Neurosci. Biobehav. Rev. 20 (1996) 367-387
108. Gottesmann C. Introduction to the neurophysiological study of sleep: central regulation of skeletal and ocular activities. Arch. Ital. Biol. 135 (1997) 279-314
109. Gottesmann C. Neurophysiological support of consciousness during waking and sleep. Prog. Neurobiol. 59 (1999) 469-508
110. Gottesmann C. The golden age of rapid eye movement sleep discoveries. I. Lucretius-1964. Prog. Neurobiol. 65 (2001) 211-287
111. Gottesmann C. Dreaming and schizophrenia. A common neurobiological background. Sleep Biol. Rhyt. 3 (2005) 64-74
112. Gottesmann C. The golden age of rapid eye movement sleep discoveries: 1965-1966 (2005), Nova Science Publishers Inc., New York
113. Gottesmann C. The dreaming sleep stage: a new neurobiological model of schizophrenia?. Neuroscience 140 (2006) 1105-1115
114. Gottesmann C. Neurobiological disturbances during the dreaming-sleep stage can explain dream bizarreness without recourse to censorship. Neuro-Psychoanalysis 8 (2006) 27-32
115. Gottesmann C., Gandolfo G., and Zernicki B. Intermediate stage of sleep in the cat. J. Physiol. Paris 79 (1984) 359-372
116. Gottesmann C., User P., and Gioanni H. Sleep: a physiological cerveau isolé stage?. Waking Sleep 4 (1980) 111-117
117. Gould T.D., and Gottesman I.I. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behavior. 5 (2006) 113-119
118. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41 (1991) 1-24
119. Grace A.A. Gating information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res. Rev. 31 (2000) 330-341
120. Green W.J., and Stajduhar P.P. The effect of ECT on the sleep-dream cycle in a psychotic depression. J. Nerv. Ment. Dis. 143 (1966) 123-134
121. Gresham S.C., Agnew H.W.J., and Williams R.L. The sleep of depressed patients. An EEG and eye movement study. Arch. Gen. Psychiat. 13 (1965) 503-507
122. Griffin J., and Tyrrell I. Human givens: a new approach to emotional health and clear thinking (2003), HG Publishing, New York
123. Grubar J.C. Sleep in mental deficiency. Rev. EEG Neurophysiol. 13 (1983) 107-114
124. Hartmann E., Verdone P., and Snyder F. Longitudinal studies and dreaming patterns in psychiatric patients. J. Nerv. Ment. Dis. 142 (1966) 117-126
125. Hasler G., Drevets W.D., Gould T.D., Gottesman I.I., and Manji H.M. Toward constructing an endophenotype strategy for bipolar disorders. Biol. Psychiat. 60 (2006) 93-105
126. Hasler G., Drevets W.C., Manji H.M., and Charmey D.S. Discovering endophenotypes for major depression. Neuropharmacology 57 (2004) 1765-1781
127. Hawkins D.R., Puryear H.B., Wallace C.D., Deal W.B., and Thomas E.S. Basal skin resistance during sleep and dreaming. Science 136 (1962) 321-322
128. Hennevin E., Hars B., Maho C., and Bloch V. Processing of learned information in paradoxical sleep: relevance for memory. Behav. Brain Res. 69 (1995) 125-135
129. Heresco-Levy U. N-methyl-d-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade. Int. J. Neuropharmacol. 3 (2000) 243-258
130. Hernandez-Peon R., Chavez-Ibarra G., Morgane P.J., and Timo-Iaria I. Limbic cholinergic pathways involved in sleep and emotional behavior. Exp. Neurol. 8 (1963) 93-111
131. Hishikawa Y., and Kaneko Z. Electroencephalographic study of narcolepsy. Electroenceph Clin. Neurophysiol. 18 (1965) 249-259
132. Hobson J.A. L'activité électrique phasique du cortex et du thalamus au cours du sommeil désynchronisé chez le Chat. C.R. Soc. Biol. 158 (1964) 2131-2135
133. Hobson J.A., McCarley R.W., and Wyzinski P.W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189 (1975) 55-58
134. Huang M., Li Z., Ichikawa J., Dai J., and Meltzer H.Y. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex. Brain Res. 1099 (2006) 44-55
135. Ising M., Kunzel H.E., Binder E.B., Nickel T., Modell S., and Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker of depression. Prog. Neuropsychopharmacol. Biol. Psychiat. 29 (2005) 1085-1093
136. Iwama K., Kawamoto T., Sakkakura H., and Kasamatsu T. Responsiveness of cat lateral geniculate at pre- and postsynaptic levels during natural sleep. Physiol. Behav. 1 (1966) 45-53
137. Jackson M.E., Frost A.S., and Moghaddam B. Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in nucleus accumbens. J. Neurochem. 78 (2001) 920-923
138. Jakovljevic M., Sagud M., and Mihaljevic-Peles A. Olanzapine in the treatment-resistant, combat-related PTSD-a series of case reports. Acta Psychiat. Scand. 107 (2003) 394-396
139. Jasper H.H., and Tessier J. Acetylcholine liberation from cerebral cortex during paradoxical (REM sleep). Science 172 (1971) 601-602
140. Johnson L.C., and Lubin A. Spontaneous electrodermal activity during waking and sleeping. Psychophysiology 3 (1966) 8-17
141. Jones B.E. Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience 40 (1991) 637-656
142. Jones B.E. Paradoxical sleep promoting and permitting neural networks. Arch. Ital. Biol. 142 (2004) 379-396
143. Jouvet M. Cholinergic mechanisms and sleep. In: Waser P.G. (Ed). Cholinergic Mechanisms (1975), Raven Press, New York 455-476
144. Jouvet M. Le sommeil et le rêve (1992), Jacob, Paris 220
145. Jouvet M., and Michel F. Corrélations électromyographiques du sommeil chez le Chat décortiqué et mésencéphalique chronique. C.R. Soc. Biol. 153 (1959) 422-425
146. Jouvet M., and Michel F. Déclenchement de la "phase paradoxale" du sommeil par stimulation du tronc cérébral chez le Chat intact et mésencéphalique chronique. C.R. Soc. Biol. 154 (1960) 636-641
147. Jouvet M., and Michel F. Nouvelles recherches sur les structures responsables de la phase paradoxale du sommeil. J. Physiol. Paris 52 (1960) 130-131
148. Jouvet M., Michel F., and Courjon J. Sur un stade d'activité électrique rapide au cours du sommeil physiologique. C.R. Soc. Biol. 153 (1959) 1024-1028
149. Keck M.E., Ohl F., Holsboer F., and Muller M.B. Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci. Biobehav. Rev. 29 (2005) 867-889
150. Kelly P.H. Defective inhibition of dream event memory formation: a hypothesized mechanism in the onset and progression of symptoms of schizophrenia. Brain Res. Bull. 46 (1998) 189-197
151. Kilduff T.S., Bowersox S.S., Katin K.I., Baker T.L., Ciaranello R.D., and Dement W.C. Muscarinic cholinergic receptors and the canine model of narcolepsy. Sleep 9 (1986) 102-106
152. Kisley M.A., Olincy A., Robbins E., Polk S.D., Adler L.E., Waldo M.C., and Freedman R. Sensory gating impairement associated with schizophrenia persists into REM sleep. Psychophysiology 40 (2003) 29-38
153. Kiyono S., and Iwama K. Phasic activity of cat's cerebral cortex during paradoxical sleep. Med. J. Osa. Univ. 16 (1965) 149-159
154. Klein M., Michel F., and Jouvet M. Etude polygraphique du sommeil chez les oiseaux. C.R. Soc. Biol. 158 (1964) 99-103
155. Krnjevic K., and Phillis J.W. Actions of certain amines on cerebral cortex neurons. Br. J. Pharmacol. 20 (1963) 471-490
156. Kuhn R. The treatment of depressive states with G 22355 (imipramine hydrochloride). Am. J. Psychiat. 115 (1958-59) 459-464
157. Laborit H., and Huguenard P. L'hibernation artificielle par moyens pharmacodynamiques et physiques. Pres. Med. 59 (1951) 1329
158. Lairy, G.C., Barros-ferreira, M., Goldsteinas, L., 1968. Données récentes sur la physiologie et la physiopathologie de l'activité onirique. In: Gastaut, H., Berti Ceroni, E.L.G., Coccagna, G. (Eds.), The Abnormalities of Sleep in Man. Aulo Gaggi, Bologna, pp. 275-283.
159. Lancel M., Grönlein T.A.M., and Faulhaber J. Role of GABAa receptors in sleep regulation. Differential effects of muscimol and midazolam on sleep in rats. Neuropsychopharmacology 15 (1996) 63-74
160. Lapiz M.D.S., and Morilak D.A. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as mesured by attentional set shifting capability. Neuroscience 137 (2005) 1039-1049
161. Larson J.D., and Foulkes D. Electromyogram suppression during sleep, dream recall and orientation time. Psychophysiology 5 (1969) 548-555
162. Lauer C.J., Krieg J.C., Rieman D., Zulley J., and Berger M. A polysomnographic study in young psychiatric inpatients: majore depression, anorexia nervosa, bulimia nervosa. J. Affect Disord. 18 (1990) 235-245
163. Lauer C.J., Rieman D., Wiegand M., and Berger M. From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biol. Psychiat. 29 (1991) 979-993
164. Lauer C.J., Schreiber W., Holsboer F., and Krieg J.C. In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch. Gen. Psychiat. 52 (1995) 145-153
165. Lauer C.J., Schreiber W., Pollmacher T., Holsboer F., and Krieg J.C. Sleep in schizophrenia: a polysomnographic study on drug-naive patients. Neuropsychopharmacology 16 (1997) 51-60
166. Lauriat T.L., Dracheva S., Chin B., Schmeidler J., McInnes L.A., and Haroutunian V. Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience 137 (2005) 843-851
167. Léna I., Parrot S., Deschaux O., Muffat S., Sauvinet V., Renaud B., Suaud-Chagny M.F., and Gottesmann C. Variations in the extracellular levels of dopamine, noradrenaline, glutamate and aspartate across the sleep-wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J. Neurosci. Res. 81 (2005) 891-899
168. Linner L., Wiker C., Wadenberg M.L., Schalling M., and Svensson T.H. Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockade-induced dopamine release in the medial prefrontal cortex of the rat. Neuropsychpharmacology 27 (2002) 691-698
169. Llinas R., and Ribary U. Coherent 40 Hz oscillation characterizes dream state in humans. Proc. Natl. Acad. Sci. USA 90 (1993) 2078-2081
170. Loomer H.P., Saunders J.C., and Kline N.S. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. In: Affects D.A. (Ed). Proceedings of the Psychiatric Research reports. New York (1957), Am. Psychiat. Assoc., 8 129-141
171. MacKay A.V., Iversen L.L., Rossor M., Spokes E., Bird E., Arregui A., and Snyder S. Increased brain dopamine and dopamine receptors in schizophrenia. Arch. Gen. Psychiat. 39 (1982) 991-997
172. Madsen P.L., Holm S., Vorstrup S., Friberg L., Lassen N.A., and Wildschiodtz G. Human regional cerebral blood flow during rapid-eye-movement sleep. J. Cerbr. Blood Flow Met. 11 (1991) 502-507
173. Mallick B.N., Majumdar S., Faisal M., Yadav V., Madan V., and Pal D. Role of norepinephrine in the regulation of rapid eye movement sleep. J. Biosci. 27 (2002) 539-551
174. Mallick B.N., Singh S., and Pal D. Role of alpha and beta adrenoceptors in locus coeruleus stimulation-induced reduction in rapid eye movement sleep in freely moving rats. Behav. Brain Res. 158 (2005) 9-21
175. Maloney K.J., Cape E.G., Gotman J., and Jones B.E. High-frequency-electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat. Neuroscience 76 (1997) 541-555
176. Maloney K.J., Mainville L., and Jones B.E. c-Fos expression in dopaminergic and GABAergic neurons of the ventral mesencephalic tegmentum oafter paradoxical sleep deprivation and recovery. Eur. J. Neurosci. 15 (2002) 774-778
177. Mansour H.A., Wood J., Logue T., Chowdari K.V., Dayal M., Kupfer D.J., Monk T.H., Devlin B., and Nimgaonkar V.L. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav. (2006)
178. Manunta Y., and Edeline J.M. Effects of noradrenaline on frequency tuning of auditory cortex neurons during wakefulness and slow wave sleep. Eur. J. Neurosci. 11 (1999) 2134-2150
179. Maquet P. Functional neuroimaging of normal sleep by positon emission tomography. J. Sleep Res. 9 (2000) 207-231
180. Maquet P., and Franck G. REM sleep and amygdala. Mol. Psychiat. 2 (1997) 195-196
181. Maquet P., Peters J.M., Aerts J., Delfiore G., Degueldre C., Luxen A., and Franck G. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature 383 (1996) 163-166
182. Marrosu F., Portas C., Mascia M.F., Casu M.A., Fa M., Giagheddu M., Imperato A., and gessa G.L. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res. 671 (1995) 329-332
183. Massimini M., Ferrarelli F., Huber R., Esser S.K., Singh H., and Tononi G. Breakdown of cortical effective connectivity during sleep. Science 309 (2005) 2228-2232
184. McCarley R.W., and Hobson J.A. Single neuron activity in desynchronized sleep. Science 167 (1971) 901-903
185. McCarley R.W., and Hobson J.A. Single neuron activity in giganto cellular tegmental field: selectivity of discharge in desynchronized sleep. Science 174 (1971) 1250-1252
186. McCarley R.W., Winkelman J.W., and Duffy F.H. Human cerebral potentials associated with REM sleep rapid eye movements: links to PGO waves and waking potentials. Brain Res. 274 (1983) 359-364
187. McCormick D.A. Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog. Neurobiol. 39 (1992) 337-388
188. McGinty D.J., and Harper R.M. Dorsal raphe neurons: depression of firing during sleep in cats. Brain Res. 101 (1976) 569-575
189. McGinty, D.J., Harper, R.M., Fairbanks, M.K., 1974. Neuronal unit activity and the control of sleep states. In: Weitzman, E.D. (Ed.), Advances in Sleep Research, vol. 1. Spectrum, New York, pp. 173-216.
190. Meyer-Lindenberg A., Olsen R.K., Kohn P.D., Brown T., Egan M.F., Weinberber D.R., and Berman K.F. Regionally specific disturbance of dorsolateral prefrontal-hippocampal function connectivity in schizophrenia. Arch. Gen. Psychiat. 62 (2005) 379-386
191. Meyer-Lindenberg A., Poline J.B., Kohn P.D., Holt J.L., Egan M.F., Weinberger D.R., and Berman K.F. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am. J. Psychiat. 158 (2001) 1809-1817
192. Meyer-Lindenberg A., and Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 7 (2006) 818-827
193. Michel F., Jeannerod M., Mouret J., Rechtschaffen A., and Jouvet M. Sur les mécanismes de l'activité de pointes au niveau du système visuel au cours de la phase paradoxale du sommeil. C.R. Soc. Biol. 158 (1964) 103-106
194. Mikiten T.M., Niebyl P.H., and Hendley C.D. EEG desynchronization during behavioral sleep associated with spike discharges from the thalamus of the cat. Fed. Proc. 20 (1961) 327
195. Miller J.D., Farber J., Gatz P., Roffwarg H., and German D. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat. Brain Res. 273 (1983) 133-141
196. Miyauchi S., Takino R., Fukuda H., and Torii S. Electrophysiological evidence for dreaming: human cerebral potentials associated with rapid eye movements during REM sleep. Electroenceph Clin. Neurophysiol. 66 (1987) 383-390
197. Mizuno S., Kameda A., Inagaki T., and Horiguchi J. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep. Psychiat. Clin. Neurosci. 58 (2004) 660-665
198. Modell S., Ising M., Holsboer F., and Lauer C.J. The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biol. Psychiat. 58 (2005) 694-699
199. Moises H.W., Zoega T., and Gottesman I.I. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiat. 2 (2002) 8
200. Moraes W.D., Povares D.R., Guilleminault C., Ramos L.R., Bertolucci P.H., and Tifik S. The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study. Sleep 29 (2006) 199-205
201. Moroz G., Foutz A.S., and Gottesmann C. Paradoxical sleep and pontine activation in the rat. In: Koella W.P., and Levin P. (Eds). Sleep 1976 (1977) 186-188
202. Murck H., Held K., Ziegenbein M., Kunzel H.E., Holsboer F., and Steiger A. Intravenous adminstration of the neuropetid galanin has fast antidepressant efficacy and affects the sleep EEG. Psychoneuroendocrinology 29 (2004) 1205-1211
203. Muzio J.N., Roffwarg H.P., and Kaufman E. Alterations in the nocturnal sleep cycle resulting from LSD. Electroenceph Clin. Neurophysiol. 21 (1966) 313-324
204. Nagamoto H.T., Adler L.E., McRae K.A., Huettl P., Cawthra E., Gerhardt G., Hea R., and Griffith J. Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol. Neuropsychobiology 39 (1999) 10-17
205. Nelson C.N., Hoffer B.J., Chu N.S., and Bloom F.E. Cytochemical and pharmacological studies on polysensory neurons in the primate frontal cortex. Brain Res. 62 (1973) 115-133
206. Nicol S.C., Andersen N.A., Phillis N.H., and Berger R.J. The echidna manifests typical characteristics of rapid eye movement sleep. Neurosci. Lett. 283 (2000) 49-52
207. Nielsen T. cognition in REM and NREM sleep: a review and possible reconciliation of two models of sleep mentation. Behav. Brain Sci. 23 (2000) 851-866
208. Nievergelt C., Kripke D.F., Barrett T.B., Burg E., Remick R.A., Sadovnick A.D., McElroy S.L., Keck P.E.J., Schork N.J., and Kelsoe J.R. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am. J. Med. Gen. Neuropsychiat. Gen. 141B (2006) 234-241
209. Nissen C., Feige B., Nofzinger E.A., Rieman D.,M.B., and Voderholzer U. Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine. J. Sleep Res. 14 (2005) 207-208
210. Nofzinger E.A., Mintun M.A., Wiseman M.B., and Kupfer J. Forebrain activation during REM sleep: an FDG PET study. Brain Res. 770 (1997) 192-201
211. Numberger J.L.J., Berretini W., Mendelson W.B., Sacks D., and Gershon E.S. Mesuring cholinergic sensitivity: arecoline effects in bipolar patients. Biol. Psychiat. 25 (1989) 610-617
212. Numberger J.L.J., Sitaram N., Gershon E.S., and Gillin J.C. A twin study of cholinergic REM induction. Biol. Psychiat. 18 (1983) 1161-1165
213. Olincy A., Harris J.G., Johnson L.L., Pender V., Kongs S., Allensworth D., Ellis J., Zerbe G.O., Leonard S., Stevens K.E., Stevens J.O., Martin L., Adler L.E., Soti F., Kem W.R., and Freedman R. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch. Gen. Psychiat. 63 (2006) 630-638
214. Onoe H., and Sakai K. Kainate receptors: a novel mechanism in paradoxical (REM) sleep generation. Neuroreport 6 (1995) 353-356
215. Ookawa T., and Gotoh J. Electroencephalographic study of chickens: periodic recurrence of low voltage and fast waves during behavioral sleep. Poult. Sci. 43 (1964) 1603-1604
216. Ookawa T., and Gotoh J. Electroencephalogram of the chicken recorded from the skull under various conditions. J. Comp. Neurol. 124 (1965) 1-14
217. Overeem S., Scammell T.E., and Lammers G.J. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy. Curr. Opin. Neurol. 15 (2002) 739-745
218. Overstreet D.H. The Flinders sensitive line rats: a genetic model of depression. Neurosci. Biobehav. Rev. 17 (1993) 51-68
219. Parsons L.M., Sergent J., Hodges D.A., and Fox P.T. The brain basis of piano performance. Neuropsychologia 43 (2005) 199-215
220. Peled A., Geva A.B., Kremen W.S., Blankfeld H.M., Esfandiarfard R., and Nordahl T.E. Functional connectivity and working memory in schizophrenia: an EEG study. Int. J. Neurosci. 106 (2000) 47-61
221. Perez-Garci E., del Rio-Portilla Y., Guevara M.A., Arce C., and Corsi-cabrera M. Paradoxical sleep is characterized by uncoupled gamma activity between frontal and perceptual cortical regions. Sleep 24 (2001) 118-126
222. Perry E., Walker M., Grace J., and Perry R. Acetylcholine in mind: a neurotransmitter of consciousness?. Trends Neurosci. 22 (1999) 273-280
223. Popa D., El Yacoubi M., Vaugeois J.M., Hamon M., and Adrien J. Homeostatic regulation of sleep in a genetic model of depression in the mouse: effects of muscarinic and 5-HT1A receptor activation. Neuropsychopharmacology 31 (2005) 1637-1646
224. Portas C.M., Thakkar M., Rainnie D., and McCarley R.W. Microdialysis perfusion of 8-hydroxy-2-′di-n-propylamine)tetralin (8-OH-dPAT) in the dorsal raphe nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving cat. J. Neurosci. 16 (1996) 2820-2828
225. Pralong E., Magistretti P., and Stoop R. Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders. Prog. Neurobiol. 67 (2002) 173-202
226. Raedler T., Knable M., Jones D., Urbina R., Gorey J., Lee K., Egan M., Coppola R., and Weinberger D. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. Am. J. Psychiat. 160 (2003) 118-127
227. Raisman R., Briley M., and Langer S.Z. Specific tricyclic antidepressant binding sites in rat brain. Nature 281 (1979) 140-150
228. Rao U., Dahl R.E., Ryan N.D., Birmaher B., Williamson D.E., Giles D.E., Rao R., Kaufman J., and Nelson B. The relationship between longitudinal clinical course and sleep and cortisol changes in adolsecent depression. Biol. Psychiat. 40 (1996) 474-484
229. Rasmussen K., Heym J., and Jacobs B.L. Activity of serotonin-containing neurons in nucleus centralis superior of freely moving cats. Exp. Neurol. 83 (1984) 302-317
230. Reader T.A., Ferron A., Descarries L., and Jasper H.H. Modulatory role for biogenic amines in the cerebral cortex. Microiontopheric studies. Brain Res. 160 (1979) 219-229
231. Rechtschaffen A., Wolpert E.A., Dement W.C., Mitchell S.A., and Fisher C. Nocturnal sleep in narcoleptics. Electroenceph Clin. Neurophysiol. 15 (1963) 599-609
232. Reeves M., Lindholm D.E., Myles P.S., Fletcher H., and Hunt J.O. Adding ketamine to morphine for patient-controlled analgesia after major abdominal surgery: a double-blind, randomized trial. Anesth. Analg. 93 (2001) 116-120
233. Ribary U., Ionnides A.A., Singh K.D., Hasson R., Bolton J., Lado F., Mogilner A., and Llinas R. Magnetic field tomography of coherent thalamocortical 40 Hz oscillations in humans. Proc. Natl. Acad. Sci. USA 88 (1991) 11037-11041
234. Risch S.C., Kalin N.H., and Janowsky D.S. Cholinergic challenges in affective illness: behavioral and neuroendocrine correlates. Psychopharmacologia 1 (1981) 186-192
235. Rush A.J., Erman M.K., Giles D.E., Schlesser M.A., Carpenter G., Vasavada N., and Roffwarg H.P. Polysomnographic findings in recently drug-free and clinical remitted depressed patients. Arch. Gen. Psychiat. 43 (1986) 878-884
236. Sakai K., and Crochet S. A neural mechanism of sleep and wakefulness. Sleep Biol. Rhyt. 1 (2003) 29-42
237. Salomon R., Ripley B., Kennedy J.S., Johnson B., Schmidt D., Zweitzer J.M., Nishino S., and Mignot F. Diurnal variations of CSF hypocretin-1 levels in control and depressed patients. Biol. Psychiat. 54 (2003) 96-104
238. Sarter M., and Bruno J.P. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience 95 (2000) 933-952
239. Satoh T. Direct cortical response and PGO spike during paradoxical sleep of the cat. Brain Res. 28 (1971) 576-578
240. Siegel J.M., Manger P.R., Nienhuis R., Fahringer H.M., and Pettigrew J.D. The echidna Tachyglossus aculeatus combines REM and non-REM aspects in single sleep state: implications for the evolution of sleep. J. Neurosci. 16 (1996) 3500-3506
241. Siegel J.M., Manger P.R., Nienhuis R., Fahringer S.T., and Pettigrew J.D. Sleep in the platypus. Neuroscience 91 (1999) 391-400
242. Siegel C., Waldo M., Mizner G., Adler L.E., and Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch. Gen. Psychiat. 41 (1984) 607-612
243. Silver H., Barash I., Aharon N., Kaplan A., and Poyurovsky M. Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study. Int. Clin. Psychopharmacol. 15 (2000) 257-261
244. Sitaram N., and Gillin J.C. Development and use of pharmacological probes of the CNS in man: evidence of cholinergic abnormality in primary affective illness. Biol. Psychiat. 15 (1980) 925-955
245. Sitaram N., Moore A.M., and Gillin J.C. The effect of physostigmine on normal human sleep and dreaming. Arch. Gen. Psychiat. 35 (1978) 1229-1243
246. Sitaram N., Moore A.M., and Gillin J.C. Induction and restting of REM sleep rhythm in normal man by arecholine: blckade by scopolamine. Sleep 1 (1978) 83-90
247. Sitaram N., Numberger J.L.J., Gershon E.S., and Gillin J.C. Faster cholinergic REM sleep induction in euthymic patients with primary affective illness. Science 208 (1980) 200-202
248. Sitaram N., Numberger J.L.J., Gershon E.S., and Gillin J.C. Cholinergic regulation of mood and REM sleep potential model and marker of vulnerability to affective disorder. Am. J. Psychiat. 139 (1982) 571-576
249. Smith C. Sleep states and memory processes. Behav. Brain Res. 69 (1995) 137-145
250. Solms M. Dreaming and REM sleep are controlled by different brain mechanisms. Behav. Brain Sci. 23 (2000) 843-850
251. Stanton T., Bodden-Watson C., Cusack B., and Richelson E. Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and histaminics. Biochem. Pharmacol. 45 (1993) 2352-2354
252. Stassen H.H., Coppola R., Gottesman I.I., Torrey E.F., Kuny S., Rickler K.C., and Hell D. EEG differences in monozygotic twins discordant and concordant for schizophrenia. Psychophysiology 36 (1999) 109-117
253. Steriade M. Ascending control of thalamic and cortical responsiveness. Int. Rev. Neurobiol. 12 (1970) 87-144
254. Steriade M., Paré D., Bouhassira D., Deschènes M., and Oakson G. Phasic activation of lateral geniculate and perigeniculate thalamic neurons during sleep with ponto-geniculate-occipital waves. J. Neurosci. 9 (1989) 2215-2229
255. Suzuki J. Narcoleptic syndrome and paradoxical sleep. Fol. Psychiat. Neurol. 20 (1966) 123-149
256. Tafti M., Chollet D., Valatx J.L., and Franken P. Quantitative trait loci approach to the genetics of sleep in recombinant inbred mice. J. Sleep Res. 8 Suppl. 1 (1999) 37-43
257. Takahata R., and Moghaddam B. Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area. J. Neurochem. 75 (2000) 1775-1778
258. Takeuchi T., Miyasita A., Inugami M., and Yamamoto Y. Intrinsic dreams are not produced without REM sleep mechanims: evidence through elicitation of sleep onset periods. J. Sleep Res. 10 (2001) 43-52
259. Takeuchi T., Ogilvie R.D., Ferrelli A.V., Murphy T., Yamamoto Y., and Inugami M. Dreams are not produced without REM sleep mechanisms. Sleep Res. Online 2 Suppl. 1 (1999) 279
260. Terao A., Wisor J.P., Peyron C., Apte-Deshpande A., Wurts S.W., Edgar D.M., and Kilduff T.S. Gene expression in the rat brain during sleep deprivation and recovery sleep: an Affymetrix GeneChip study. Neuroscience 137 (2006) 593-605
261. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., and Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27 (2000) 464-474
262. Thomas D.R., Melotto S., Massagrande M., Gribble A.D., Jeffrey P., Stevens A.J., Deeks N.J., Eddershaw P.J., TFenwick S.H., Riley G., Stean T., Scott C.M., Hill M.J., Middlemiss D.N., Hagan J.J., Price G.W., and Forbes I.T. SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats. Br. J. Pharmacol. 139 (2003) 705-714
263. Thompson D.F., and Pierce D.R. Drug-indiced nightmares. Ann. Pharmacother. 33 (1999) 93-98
264. Tokizane T. Hypothalamic control of cortical activity and some observations during different stages of sleep. Electroenceph Clin. Neurophysiol. 17 (1964) 450
265. Toyoda J. The effects of chlorpromazine and imipramine on the human nocturnal sleep electroencephalogram. Folia Psychiat. Neurol. 18 (1964) 198-221
266. Tradarti V. Sleep in the pigeon. Arch. Ital. Biol. 104 (1966) 516-521
267. Trulson M.E., and Preussler D.W. Dopamine-containing ventral tegmental area neurons in freely moving cats: activity during the sleep-waking cycle and effects of stress. Exp. Neurol. 83 (1984) 367-377
268. Van Hes R., Smid P., Stroomer C.N., Tipker K., Tulp M.T., Van der Heyden J.A., McCreary A.C., Hesselink M.B., and Kruse C.G. SL V310, a novel, potential antipsychotic, combining potent dopamine d2 receptor antagonism with serotonin reuptake inhibition. Bioorg. Med. Chem. Lett. 13 (2003) 405-408
269. Vasquez J., and Baghdoyan H.A. Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking. Am. J. Physiol. 280 (2001) R598-R601
270. Vertes R.P. Selective firing of rat pontine gigantocellular neurons during movement and REM sleep. Brain Res. 128 (1977) 146-152
271. Vincent J.D., Favarel-Garrigues B., Faure J., and Julien J. Sur un cas de narcolepsie avec des phénomènes végétatifs paroxystiques: étude diurne et nocturne. Rev. Neurol. 115 (1966) 464-468
272. Vogel G. Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs. Neuro-Psychopharmacol. Biol. Psychiat. 7 (1983) 343-349
273. Vogel G., Feng P., and Kinney G.G. Ontogeny of REM sleep in rats. Possible implications for endogenous depression. Physiol. Behav. 68 (2000) 453-461
274. Vogel G., Foulkes D., and Trosman H. Ego functions and dreaming during sleep onset. Arch. Gen. Psychiat. 14 (1966) 238-248
275. Vogel G.W., Thompson F.C.J., Thurmon A., and Rivers B. The effect of REM deprivation on depression. Psychosomatics 14 (1973) 104-107
276. Wall P.D. Excitability changes in afferent fiber terminaisons and their relation to slow potential. J. Physiol London 142 (1958) 1-21
277. Wehr T.A., Wirz-Justice A., Goodwin F.K., Duncan W., and Gillin J.C. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 206 (1979) 710-713
278. Weinberger D.R., Berman K.F., and Zec R.F. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. 1. Regional cerebral blood flow evidence. Arch. Gen. Psychiat. 43 (1986) 114-124
279. Weiss T., and Adey W.R. Excitability changes during paradoxical sleep in the rat. Experentia 21 (1965) 1-4
280. Yavari P., Vogel G.W., and Neill D.B. Decreased raphe unit activity in a rat model of endogenous depression. Brain Res. 611 (1993) 31-36
281. Young C.E., Beach T.G., Falkai P., and Honer W.G. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cer. Cort. 8 (1998) 261-268
282. Zarcone V.P., Azumi K., Dement W., Gulevich G., Kraemer H., and Pivik T. REM phase deprivation and schizophrenia II. Arch. Gen. Psychiat. 32 (1975) 1431436
283. Zarcone V.P., Gulevich G., Pivik T., Azumi K., and Dement W. REM deprivaztion and schizophrenia. Biol. Psychiat. 1 (1969) 179-184
284. Zhang B., Veasey S., Wood M.A., Leng L.Z., Kaminski C., Leight S., Abel T., Lee V.M., and Trojanowski J. Impaired rapid eye movementsleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons. Am. J. Pathol. 167 (2005) 1361-1369
285. Zubenko G.S., Maher B., Hughes H.B., Zubenko W.N., Stiffler J.F., Kaplan B.B., and Marazita M.L. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am. J. Genet. B Neuropsychiat. Genet. 123 (2003) 1-18